Docusate Sodium
NDC 76420-225, Docusate Sodium, capsule, liquid filled, from Asclemed USA, Inc..
- Product NDC
- 76420-225
- Status
- Listed
- Labeler
- Asclemed USA, Inc.
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M007
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76420-225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOCUSATE SODIUM100 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76420-225-30 | 76420022530 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (76420-225-30) |
| 76420-225-60 | 76420022560 | 60 CAPSULE, LIQUID FILLED in 1 BOTTLE (76420-225-60) |
| 76420-225-90 | 76420022590 | 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (76420-225-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 76420-225 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76420-225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76420-225. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.